Clinical Trials
2 trialsNCT01167114 2023-11-02
STA-9090 in Previously Treated Patients With Advanced Esophagogastric Cancer
Massachusetts General Hospital
Phase 2 Completed
NCT02296671 2016-03-08
Personalized Therapy for Esophagogastric Cancer Using Thymidylate Synthase Genetic Markers
Washington University School of Medicine
Phase 2 Withdrawn